PLA2G6 and Parkinson disease: Since many of the pathological hallmarks of PLA2G6 disorders including the accumulation of brain iron, are also observed in Alzheimer’s and Parkinsons disease, any genes or compounds that suppress these phenotypes may also have therapeutic effects in a broad spectrum of neurodegenerative diseases.